Healthequity Stock Filter Stocks by Fundamentals
HQY Stock | USD 79.87 0.40 0.50% |
HealthEquity fundamentals help investors to digest information that contributes to HealthEquity's financial success or failures. It also enables traders to predict the movement of HealthEquity Stock. The fundamental analysis module provides a way to measure HealthEquity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HealthEquity stock.
Price To Book Ratio is likely to rise to 5.76 in 2024. HealthEquity | Price to Book |
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
All Next | Launch Module |
HealthEquity Fundamentals
Return On Equity | 0.0284 | ||||
Return On Asset | 0.0256 | ||||
Profit Margin | 0.06 % | ||||
Operating Margin | 0.16 % | ||||
Current Valuation | 7.45 B | ||||
Shares Outstanding | 86.16 M | ||||
Shares Owned By Insiders | 2.22 % | ||||
Shares Owned By Institutions | 97.78 % | ||||
Number Of Shares Shorted | 2.98 M | ||||
Price To Earning | 525.29 X | ||||
Price To Book | 3.38 X | ||||
Price To Sales | 6.88 X | ||||
Revenue | 999.59 M | ||||
Gross Profit | 490.09 M | ||||
EBITDA | 281.21 M | ||||
Net Income | 55.71 M | ||||
Cash And Equivalents | 176.89 M | ||||
Cash Per Share | 2.09 X | ||||
Total Debt | 933.14 M | ||||
Debt To Equity | 0.54 % | ||||
Current Ratio | 2.46 X | ||||
Book Value Per Share | 23.63 X | ||||
Cash Flow From Operations | 242.83 M | ||||
Short Ratio | 5.20 X | ||||
Earnings Per Share | 0.64 X | ||||
Price To Earnings To Growth | 2.29 X | ||||
Target Price | 99.23 | ||||
Number Of Employees | 3.13 K | ||||
Beta | 0.55 | ||||
Market Capitalization | 6.92 B | ||||
Total Asset | 3.24 B | ||||
Retained Earnings | 205.63 M | ||||
Working Capital | 440.35 M | ||||
Current Asset | 143.05 M | ||||
Current Liabilities | 12.11 M | ||||
Net Asset | 3.24 B |
About HealthEquity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HealthEquity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HealthEquity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HealthEquity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out HealthEquity Piotroski F Score and HealthEquity Altman Z Score analysis. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for HealthEquity Stock analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share 0.64 | Revenue Per Share 11.682 | Quarterly Revenue Growth 0.122 | Return On Assets 0.0256 |
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.